Treat Psoriasis with Topical Corticosteroids to decrease the Risk of Metabolic Syndrome
Psoriasis is a chronic autoimmune disease in which the body overproduces skin cells, cautilizing thick, red, dry, scaly patches of inflammation on the skin. Nearly 8 million Americans have psoriasis. Psoriasis sufferers with less than 2% of their body affected are considered to have a mild case; those with 3% to 10% of their body affected are considered to have a moderate case, although those with far more than 10 percent of their body affected are considered to have a severe case of psoriasis.
For a few as-yet-unknown reason, individuals with psoriasmight be are at double the risk of metabolic syndrome, a cluster of risk factors for diabetes and heart disease. Metabolic syndrome dramatically increases the risk of sort 2 diabetes, heart attack, stroke and peripheral vascular disease (harm to or blockage in the arteries). Folks with 3 or more of the following are considered to have metabolic ...
psoriasis treatment topical corticosteroids,
No comments:
Post a Comment